Sangamo Therapeutics Q3 EPS $(0.11) Misses $(0.01) Estimate, Sales $581.000K Miss $34.400M Estimate

Sangamo Therapeutics (NASDAQ: SGMO) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.01) by 1275 percent. This is a 375 percent decrease over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $581.000 thousand which missed the analyst consensus estimate of $34.400 million by 98.31 percent. This is a 98.82 percent decrease over sales of $49.412 million the same period last year.